Back

Empagliflozin suppresses the differentiation/maturation of human epicardial preadipocytes and improves paracrine secretome profile

25 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Improving outcomes in heart failure: bench to bedside Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hidekazu Kondo

Hasama Campus - Faculty of Medicine, Oita University, Yufu City (Japan)

8 More presentations in this session

Presentation thumbnail
Are heart failure patients with mildly reduced ejection fraction treated according to current international guidelines?
Doctor T. Schupp (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
The power of optimal medical therapy in heart failure with secondary mitral regurgitation
Unknown A. Borrellas Martin (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction
Doctor F. Hofer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Successful treatment of pulmonary hypertension and right heart failure by antibody-based functional blocking of the extra-domain A of fibronectin in a preclinical animal model
Professor M. Franz (Rotenburg an der Fulda, DE)
Abstract Slides Video
Presentation thumbnail
Effects of colchicine treatment after myocardial infarction on top of standard therapy: evidence from a preclinical study
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving outcomes in heart failure: bench to bedside

The Event

Event poster

ESC Congress 2023

25 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue-derived adipo-cytokines induce pro-oxidant and pro-remodeling responses in atrial endothelial cells: synergic inhibitory effects of SGLT2 inhibition and GLP-1R activation
thumbnail
Congress Presentation
Human epicardial adipose tissue-derived factors promote atrial endothelial dysfunction: role of pro-inflammatory cytokines and AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
thumbnail
Congress Presentation
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources